South London and Maudsley NHS Trust
London, SE8, United Kingdom
NCT Number: NCT04556331
To pilot a brief group early intervention aimed at reducing or preventing the intergenerational transmission of anxiety, with parents whose child is between 12 and 47 months. To explore feasibility and acceptability of such an intervention with this population.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
London, SE8, United Kingdom
All participants will attend two group sessions of 'psychoeducation' (psychologically informed information about the topic of transmitting anxiety) and cognitive-behavioural strategies aimed at reducing the transmission of anxiety from parent to young child. The two sessions will be delivered online via Microsoft Teams, last 2 hours each and will run one week apart. Outcome and acceptability measures will be collected before, immediately after, and 6 weeks after the intervention. Feasibility data (e.g. drop-out rate) will be recorded.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
'Psychoeducation' (psychologically informed information about the topic of transmitting anxiety) and cognitive-behavioural strategies aimed at reducing the transmission of anxiety from parent to young child. These will be shared with a group of maximum 8 remotely delivered, in a didactic format.
Time frame: Total across recruitment period (up to 11 weeks, October 2020 to mid December 2020)
Percentage of count (people consent to take part / people expressing interest in response to advertising). To indicate feasibility of larger trial.
Time frame: Total across intervention period (up to 9 weeks, mid October 2020 to mid December 2020)
Percentage of count (people scheduled to attend each session / people who actually attended). To indicate feasibility of larger trial.
Time frame: Total across intervention and 6 week follow-up period (up to 15 weeks, mid October 2020 to January 2021)
Percentage of recruited participants who completed questionnaire measures at each of the three collection timepoints.
Time frame: Collected twice: immediately after intervention attendance (same day) and after 6 weeks.
Validated measure of acceptability of an intervention - Acceptability of Intervention Measure (AIM) and Intervention Appropriateness Measure (IAM) (Weiner, Lewis et al. 2017)
Time frame: Collected twice: immediately after intervention attendance (same day) and after 6 weeks.
Open text questions to gather qualitative information about participants' perspectives on usefulness, accessibility and unintended negative consequences
Time frame: Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.
Parent report measure of child social, emotional and behavioural difficulties. This is a 42-item parent-report screening tool validated with parents of children aged 12 to 47 months. Maximum score is 84 and minimum score is 0. The higher the score the worse the outcome.
Time frame: Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.
Parent report questionnaire measure of stress, anxiety and depression in parents. This is a 21-item scale. The minimum score is 0 and the maximum score is 63, higher score is a worse outcome.
Time frame: Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.
Bespoke questionnaire about 8 specific parenting behaviours targeted in the intervention, each rated on a 5-point Likert scale (4 are reverse scored). Minimum score is 0 and maximum score is 40. The higher the score the 'worse' the outcome.
King's College London
Other
Brief Online Group Parenting Programme for Anxious Parents of 1-3 Year Olds With the Aim of Reducing Transmission of Anxiety Through Generations: A Feasibility Study
Acronym: StS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06273228
Anxiety, Anxiety Disorders
Eugene, Oregon, United States
View Trial DetailsNCT05264415
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT03413631
Anxiety, Anxiety Disorders
Turku, Finland
View Trial DetailsNCT01509573
Acquired Immunodeficiency Syndrome, Anxiety
Rwinkwavu, Rwanda
View Trial Details